Antiviral Res
- VANDERLINDEN E, Boonen A, Noppen S, Schoofs G, et al
PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin
binding.
Antiviral Res. 2023;217:105700.
- CORONA A, Madia VN, De Santis R, Manelfi C, et al
Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication.
Antiviral Res. 2023;217:105697.
BMJ
- IACOBUCCI G
Covid-19: A year is too long to wait for UK inquiry's recommendations, say
bereaved families.
BMJ. 2023;382:1853.
- SIVAN M, Lawrence RR, Francis E
Digital interactive patient reported outcome measures for long term conditions.
BMJ. 2023;382:1816.
- PAGEL C
Covid is on the rise again-so what next?
BMJ. 2023;382:p1885.
- LANG K
How do we best use Paxlovid and other covid antivirals?
BMJ. 2023;382:p1666.
- DYER O
Covid-19: Infections climb globally as EG.5 variant gains ground.
BMJ. 2023;382:p1900.
Clin Infect Dis
- LIANG TJ, Law JLM, Pietschmann T, Ray SC, et al
Challenge Inoculum for Hepatitis C Virus Controlled Human Infection Model.
Clin Infect Dis. 2023;77.
- GVINJILIA L, Baliashvili D, Shadaker S, Averhoff F, et al
Impact of HCV infection and treatment on mortality in the country of Georgia,
2015-2020.
Clin Infect Dis. 2023 Apr 26:ciad182. doi: 10.1093.
- JOFFE AR, Elliott A, Eapen R, Milburn C, et al
Is vaccination acting as a placebo in preventing symptoms of Long-COVID?
Clin Infect Dis. 2023 Apr 19:ciad234. doi: 10.1093.
- VAN EFFELTERRE T, Hens N, White LJ, Gravenstein S, et al
Modeling Respiratory Syncytial Virus Adult Vaccination in the United States with
a Dynamic Transmission Model.
Clin Infect Dis. 2023 Mar 23:ciad161. doi: 10.1093.
Emerg Infect Dis
- MOONAN PK, Smith JP, Borah BF, Vohra D, et al
Home-Based Testing and COVID-19 Isolation Recommendations, United States.
Emerg Infect Dis. 2023;29.
- ANDRONESCU LR, Richard SA, Laing ED, Pisanic N, et al
Evaluating SARS-CoV-2 Saliva and Dried Blood Spot Surveillance Strategies in a
Congregate Population.
Emerg Infect Dis. 2023;29.
Int J Infect Dis
- MIDDELKOOP K, Stewart J, Walker N, Delport C, et al
Vitamin D supplementation to prevent tuberculosis infection in South African
schoolchildren: multicenter phase 3 double-blind randomized placebo-controlled
trial (ViDiKids).
Int J Infect Dis. 2023;134:63-70.
- WAILI BA, Yazidi LA, Hashami HA, Gheilani MA, et al
A comparative study of SARS-CoV-2 and common human coronavirus infections among
children presenting to tertiary care in Oman.
Int J Infect Dis. 2023 Aug 9:S1201-9712(23)00690.
- LOW EV, Pathmanathan MD, Chidambaram SK, Kim WR, et al
Real world nirmatrelvir-ritonavir outpatient treatment in reducing
hospitalization for high-risk COVID-19 patients during Omicron BA.4, BA.5 and XBB
subvariants dominance in Malaysia: A retrospective cohort study.
Int J Infect Dis. 2023 Aug 9:S1201-9712(23)00688.
- CHAE C, Kim RK, Jang EJ, Shim JA, et al
Comparing the Effectiveness of Bivalent and Monovalent COVID-19 Vaccines against
COVID-19 Infection during the Winter Season of 2022-2023: A Real-World
Retrospective Observational Matched Cohort Study in the Republic of Korea.
Int J Infect Dis. 2023 Aug 10:S1201-9712(23)00695.
- EDELSTEIN M, Beiruti KW, Ben-Amram H, Beer N, et al
Vaccine-induced and hybrid immunity to SARS-CoV-2 after three or four doses of
BNT162b2 - results from 22 months follow-up of a healthcare workers cohort,
Israel, 2020-2022.
Int J Infect Dis. 2023 Aug 10:S1201-9712(23)00694.
- JANHA RE, Bah A, Jah H, Touray F, et al
SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves
in The Gambia.
Int J Infect Dis. 2023 Aug 14:S1201-9712(23)00697.
Intensive Care Med
- SHEPHERD JM, Ross J, Anton L, Rourke C, et al
Safety and efficacy of artesunate treatment in severely injured patients with
traumatic hemorrhage. The TOP-ART randomized clinical trial.
Intensive Care Med. 2023;49:922-933.
J Infect
- WHITAKER HJ, Tsang RS, Byford R, Aspden C, et al
COVID-19 vaccine effectiveness against hospitalisation and death of people in
clinical risk groups during the Delta variant period: English primary care
network cohort study.
J Infect. 2023 Aug 12:S0163-4453(23)00456-5. doi: 10.1016/j.jinf.2023.
- WAGENHAUSER I, Mees J, Reusch J, Lam TT, et al
Determinants of Influenza A Infection Rate in Post-COVID-19 Era.
J Infect. 2023 Aug 9:S0163-4453(23)00455-3. doi: 10.1016/j.jinf.2023.
J Med Virol
- SUN Z, Wang S, Sun X, Shi Y, et al
COVID-19 has causal effects on cancer risk? Something we might ignore.
J Med Virol. 2023;95:e29034.
- BAUER C, Mack E, Hefter V, Fischer A, et al
Impaired systemic nucleocapsid antigen clearance in severe COVID-19.
J Med Virol. 2023;95:e29032.
- MAK WA, Visser W, van der Vliet M, Markus HY, et al
Ancestral SARS-CoV-2 and Omicron BA.5-specific neutralizing antibody and T-cell
responses after Omicron bivalent booster vaccination in previously infected and
infection-naive individuals.
J Med Virol. 2023;95:e28989.
- DAS A, Meng W, Liu Z, Hasib MM, et al
Molecular and immune signatures, and pathological trajectories of fatal COVID-19
lungs defined by in situ spatial single-cell transcriptome analysis.
J Med Virol. 2023;95:e29009.
- LU S, Luo S, Bai B, Fan Z, et al
Omicron breakthrough infections in wild-type SARS-CoV-2 vaccinees elicit high
levels of neutralizing antibodies against pangolin coronavirus GX_P2V.
J Med Virol. 2023;95:e29031.
J Travel Med
- ZHANG Y, Liu Y, Gao Y, Man S, et al
An alarming rise in COVID-19-related acute macular Neuroretinopathy in China: a
cross-sectional multimodal imaging study.
J Travel Med. 2023 Aug 10:taad109. doi: 10.1093.
J Virol
- LEONARD RA, Rao VN, Bartlett A, Froggatt HM, et al
A low-background, fluorescent assay to evaluate inhibitors of diverse viral
proteases.
J Virol. 2023 Aug 14:e0059723. doi: 10.1128/jvi.00597.
- JIN H, Cheng L, Gong Y, Zhu Y, et al
Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell
receptor and viral fusion protein.
J Virol. 2023 Aug 14:e0019223. doi: 10.1128/jvi.00192.
- ZHANG W, Shi K, Geng Q, Herbst M, et al
Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
J Virol. 2023 Aug 14:e0082223. doi: 10.1128/jvi.00822.
JAMA
- RAGLOW Z, Malani PN, Petty LA
Outpatient Treatment for COVID-19.
JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.16666.
- RUBIN R
Why Blood Type Seems to Be Linked With COVID-19 Risk.
JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.15996.
- DOS SANTOS RAS, Taccone FS, Annoni F
Renin-Angiotensin System Modulation in Adults With COVID-19.
JAMA. 2023;330:663-664.
- SELF WH, DeClercq J, Orr M
Renin-Angiotensin System Modulation in Adults With COVID-19-Reply.
JAMA. 2023;330:664-665.
Lancet
- IFTEKHAR N, Sivan M
Venous insufficiency and acrocyanosis in long COVID: dysautonomia.
Lancet. 2023;402:e9.
- KNAUL FM, Arreola-Ornelas H, Touchton M, McDonald T, et al
Setbacks in the quest for universal health coverage in Mexico: polarised
politics, policy upheaval, and pandemic disruption.
Lancet. 2023 Aug 7:S0140-6736(23)00777-8. doi: 10.1016/S0140-6736(23)00777.
Lancet Infect Dis
- ABO YN, Jamrozik E, McCarthy JS, Roestenberg M, et al
Strategic and scientific contributions of human challenge trials for vaccine
development: facts versus fantasy.
Lancet Infect Dis. 2023 Aug 10:S1473-3099(23)00294.
- GRANT R, Benamouzig D, Catton H, Cheng VC, et al
COVID-19 pandemic: a catalyst for accelerating global action on patient safety.
Lancet Infect Dis. 2023 Aug 9:S1473-3099(23)00485.
MMWR Morb Mortal Wkly Rep
- MONTOY JCC, Ford J, Yu H, Gottlieb M, et al
Prevalence of Symptoms =12 Months After Acute Illness, by COVID-19 Testing Status
Among Adults - United States, December 2020-March 2023.
MMWR Morb Mortal Wkly Rep. 2023;72:859-865.
- FORD ND, Slaughter D, Edwards D, Dalton A, et al
Long COVID and Significant Activity Limitation Among Adults, by Age - United
States, June 1-13, 2022, to June 7-19, 2023.
MMWR Morb Mortal Wkly Rep. 2023;72:866-870.
- NAVARRETE J, Barone G, Qureshi I, Woods A, et al
SARS-CoV-2 Infection and Death Rates Among Maintenance Dialysis Patients During
Delta and Early Omicron Waves - United States, June 30, 2021-September 27, 2022.
MMWR Morb Mortal Wkly Rep. 2023;72:871-876.
- LINK-GELLES R, Ciesla AA, Rowley EAK, Klein NP, et al
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing
COVID-19-Associated Emergency Department and Urgent Care Encounters Among
Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June
2023.
MMWR Morb Mortal Wkly Rep. 2023;72:886-892.
N Engl J Med
- RUSSELL FM, Curtis N, Carlin J
Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
N Engl J Med. 2023;389:578-579.
- LADHANI SN, Andrews N, Ramsay ME
Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
N Engl J Med. 2023;389:579.
- MARINE JE
Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
N Engl J Med. 2023;389:579.
- MURRAY EJ, Cowger TL, Hall KT
Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
Reply.
N Engl J Med. 2023;389:580.
Nature
- NUWER R
Chinese students stay local as favour falls with study abroad.
Nature. 2023;620:S11-S13.
- KOZLOV M
Key alert system for disease outbreaks is in crisis - can it be saved?
Nature. 2023;620:476-477.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016